A detailed history of Ashfield Capital Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Ashfield Capital Partners, LLC holds 79,887 shares of MRK stock, worth $7.94 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
79,887
Previous 79,887 -0.0%
Holding current value
$7.94 Million
Previous $7.28 Million 5.53%
% of portfolio
0.58%
Previous 0.57%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022

BUY
$73.51 - $82.4 $62,777 - $70,369
854 Added 1.08%
79,887 $6.56 Million
Q4 2021

Feb 02, 2022

SELL
$72.28 - $90.54 $43,368 - $54,324
-600 Reduced 0.75%
79,033 $6.06 Million
Q3 2021

Nov 09, 2021

SELL
$71.68 - $78.83 $44,154 - $48,559
-616 Reduced 0.77%
79,633 $5.98 Million
Q2 2021

Aug 09, 2021

SELL
$70.31 - $77.77 $195,391 - $216,122
-2,779 Reduced 3.35%
80,249 $6.24 Million
Q1 2021

May 11, 2021

SELL
$68.86 - $81.11 $74,024 - $87,193
-1,075 Reduced 1.28%
83,028 $6.4 Million
Q4 2020

Feb 02, 2021

SELL
$71.77 - $79.65 $51,961 - $57,666
-724 Reduced 0.85%
84,103 $6.88 Million
Q3 2020

Nov 03, 2020

SELL
$73.18 - $82.95 $2,561 - $2,903
-35 Reduced 0.04%
84,827 $7.04 Million
Q2 2020

Aug 05, 2020

BUY
$70.42 - $80.13 $278,370 - $316,753
3,953 Added 4.89%
84,862 $6.56 Million
Q1 2020

May 06, 2020

BUY
$63.36 - $87.82 $18,057 - $25,028
285 Added 0.35%
80,909 $6.23 Million
Q4 2019

Feb 07, 2020

SELL
$77.58 - $87.54 $243,135 - $274,350
-3,134 Reduced 3.74%
80,624 $7.33 Million
Q3 2019

Oct 31, 2019

BUY
$76.08 - $82.93 $166,767 - $181,782
2,192 Added 2.69%
83,758 $7.05 Million
Q2 2019

Jul 29, 2019

SELL
$69.84 - $81.59 $19,066 - $22,274
-273 Reduced 0.33%
81,566 $6.84 Million
Q1 2019

Apr 30, 2019

BUY
$69.58 - $79.36 $25,327 - $28,887
364 Added 0.45%
81,839 $6.81 Million
Q4 2018

Feb 13, 2019

BUY
$65.24 - $75.71 $11,938 - $13,854
183 Added 0.23%
81,475 $6.23 Million
Q3 2018

Nov 02, 2018

SELL
$57.69 - $67.84 $6,576 - $7,733
-114 Reduced 0.14%
81,292 $5.77 Million
Q1 2018

May 02, 2018

SELL
$50.96 - $59.23 $46,016 - $53,484
-903 Reduced 1.1%
81,406 $4.43 Million
Q4 2017

Feb 13, 2018

SELL
$51.62 - $61.64 $176,024 - $210,192
-3,410 Reduced 3.98%
82,309 $4.63 Million
Q3 2017

Nov 07, 2017

BUY
$58.67 - $63.13 $352 - $378
6 Added 0.01%
85,719 $5.49 Million
Q2 2017

Aug 14, 2017

BUY
N/A
85,713
85,713 $5.49 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Ashfield Capital Partners, LLC Portfolio

Follow Ashfield Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashfield Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ashfield Capital Partners, LLC with notifications on news.